CL2008001476A1 - PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSIVE AGENT AND AN ANTI-VIRAL AGENT; AND ITS USE TO TREAT POST-HERPETIC NEURALGIA. - Google Patents
PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSIVE AGENT AND AN ANTI-VIRAL AGENT; AND ITS USE TO TREAT POST-HERPETIC NEURALGIA.Info
- Publication number
- CL2008001476A1 CL2008001476A1 CL200801476A CL2008001476A CL2008001476A1 CL 2008001476 A1 CL2008001476 A1 CL 2008001476A1 CL 200801476 A CL200801476 A CL 200801476A CL 2008001476 A CL2008001476 A CL 2008001476A CL 2008001476 A1 CL2008001476 A1 CL 2008001476A1
- Authority
- CL
- Chile
- Prior art keywords
- agent
- combination
- pharmaceutical composition
- herpetic neuralgia
- convulsive
- Prior art date
Links
- 206010036376 Postherpetic Neuralgia Diseases 0.000 title 1
- 239000001961 anticonvulsive agent Substances 0.000 title 1
- 239000003443 antiviral agent Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2007006093A MX2007006093A (en) | 2007-05-21 | 2007-05-21 | Pharmaceutical composition combining an anticonvulsant agent and an antiviral agent. |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008001476A1 true CL2008001476A1 (en) | 2008-07-11 |
Family
ID=40032120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200801476A CL2008001476A1 (en) | 2007-05-21 | 2008-05-20 | PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSIVE AGENT AND AN ANTI-VIRAL AGENT; AND ITS USE TO TREAT POST-HERPETIC NEURALGIA. |
Country Status (7)
Country | Link |
---|---|
AR (1) | AR066668A1 (en) |
CL (1) | CL2008001476A1 (en) |
CO (1) | CO6241103A2 (en) |
MX (1) | MX2007006093A (en) |
PE (1) | PE20090292A1 (en) |
UY (1) | UY31095A1 (en) |
WO (1) | WO2008143490A1 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2230863T3 (en) * | 1998-07-09 | 2005-05-01 | Warner-Lambert Company Llc | PHARMACEUTICAL COMPOSITION CONTAINING GABA ANALOGS AND AN ANTIVIRICAL AGENT FOR THE TREATMENT OF HERPRES ZOSTER. |
-
2007
- 2007-05-21 MX MX2007006093A patent/MX2007006093A/en not_active Application Discontinuation
-
2008
- 2008-05-19 WO PCT/MX2008/000061 patent/WO2008143490A1/en active Application Filing
- 2008-05-19 UY UY31095A patent/UY31095A1/en not_active Application Discontinuation
- 2008-05-20 CL CL200801476A patent/CL2008001476A1/en unknown
- 2008-05-20 PE PE2008000866A patent/PE20090292A1/en not_active Application Discontinuation
- 2008-05-21 AR ARP080102159A patent/AR066668A1/en unknown
-
2009
- 2009-11-11 CO CO09128266A patent/CO6241103A2/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
PE20090292A1 (en) | 2009-04-04 |
AR066668A1 (en) | 2009-09-02 |
MX2007006093A (en) | 2009-02-25 |
WO2008143490A1 (en) | 2008-11-27 |
CO6241103A2 (en) | 2011-01-20 |
UY31095A1 (en) | 2008-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011000527A1 (en) | Compounds derived from benzofuran; pharmaceutical composition that includes them; and their use in the treatment of hepatitis c. | |
CL2008000063A1 (en) | MICROCAPSULA THAT INCLUDES AN AGLOMERATION OF PRIMARY MICROCAPSULES AND A LOAD SUBSTANCE; PREPARATION PROCESS; AND ITS USE TO DELIVER A LOAD SUBSTANCE TO A SUBJECT. | |
CL2007002021A1 (en) | COMPOUNDS DERIVED FROM OXOISOINDOL; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM; AND ITS USE TO TREAT ARRITMIAS. | |
CL2008000793A1 (en) | COMPOUNDS DERIVED FROM DIHYDROINDAZOL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT AN IRON DISORDER. | |
BRPI0814593A2 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND. | |
CL2008000794A1 (en) | COMPOUNDS DERIVED FROM BIARILO AND HETEROARILO; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT AN IRON DISORDER. | |
CL2008002319A1 (en) | Compounds derived from pyrrolopyrimidine; pharmaceutical composition comprising said compounds; and its use to treat cancer. | |
CL2007003565A1 (en) | COMPOUNDS DERIVED FROM REPLACED PIPERIDINS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT AN HIV INFECTION. | |
CL2008000094A1 (en) | COMPOUNDS DERIVED FROM PTERIDINE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO INCREASE VASODILATATION. | |
BRPI0815170A2 (en) | Pharmaceutical composition comprising an sglt 2 inhibitor | |
CL2008001334A1 (en) | ANTI-MUC16 ANTIBODY DESIGNED WITH CISTEINE; CONJUGADO THAT UNDERSTANDS IT; METHOD OF PRODUCTION; PHARMACEUTICAL FORMULATION THAT UNDERSTANDS IT; AND ITS USE TO TREAT CANCER. | |
CL2008003712A1 (en) | Compounds derived from thiadiazoloxyphenylamidine or thiazolyloxyphenylamidine; its preparation procedure; use and procedure to combat unwanted microorganisms; agent comprising said compounds; intermediate compounds; and its preparation procedure. | |
CL2011001232A1 (en) | Pharmaceutical combination comprising an antibody that specifically recognizes cd38 and at least cytarabine; and its use for cancer treatment | |
CL2007002916A1 (en) | COMPOUNDS DERIVED FROM PIRAZOLILTIENOPIRIDINAS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE INHIBITION OF ESCARAS. | |
CL2007002971A1 (en) | COMPOUNDS DERIVED FROM AMINOMETIL-4-IMIDAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM; AND ITS USE TO TREAT DEPRESSION, ANXIETY, BIPOLAR DISORDER, AMONG OTHERS. | |
CL2011002595A1 (en) | Use of a combination of an anticancer agent and an antioxidant to treat cancer; and pharmaceutical composition comprising said combination. | |
CL2008001835A1 (en) | Use of polycyclic guanine derived compounds to treat inflammation; guanine derived compounds; and pharmaceutical composition that includes them. | |
CL2007002818A1 (en) | PROCEDURE TO COMBAT ANIMAL PESTS OR FITOPATOGEN FUNGES; AGROCHEMICAL COMPOSITION FOR THE APPLICATION IN THE FLOOR THAT CONTAINS AT LEAST AN AGROCHEMICAL ACTIVE PRINCIPLE AND AN ASSISTANT; USE OF THE ASSISTANT TO PREPARE AGROCHEMICAL COMPOSITIONS | |
CL2007002970A1 (en) | COMPOUNDS DERIVED FROM AMINOMETIL-4-IMIDAZOL; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM; AND ITS USE TO TREAT DEPRESSION, ANXIETY, BIPOLAR DISORDER, AMONG OTHERS. | |
CL2007003232A1 (en) | COMPOUNDS DERIVED FROM 5-HYDROXIMETHYL OXAZOLIDIN-2-ONA; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT AND PREVENT BACTERIAL INFECTIONS. | |
CL2007003644A1 (en) | ANTIPARASITARY COMPOSITION THAT INCLUDES A COMPOSITE DERIVED FROM REPLACED PIRAZOL AND A SECOND ANTIPARASITARY AGENT; KIT THAT UNDERSTANDS IT; AND USE TO TREAT A PARASITARY INFESTATION. | |
CR10454A (en) | LOW-DOSE NEW PHARMACEUTICAL COMPOSITIONS THAT INCLUDE NIMESULIDE, PREPARATION AND USE OF THE SAME | |
CL2008000463A1 (en) | COMPOUNDS DERIVED FROM SUBSTITUTED BENZOFURANS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT PARASITARY INFECTIONS. | |
CL2007003643A1 (en) | PHARMACEUTICAL COMPOSITION OF AZIMILIDINE THAT INCLUDES 0.5% TO APPROXIMATELY 2.5% (W / W) OF WATER; AND USE FOR THE TREATMENT OF CARDIAC ARRITMIAS. | |
BR112013014189A2 (en) | pharmaceutical composition comprising transcinamaldehyde and its use in the treatment of infections |